EXICURE, INC.
Develops nucleic acid therapies via its SNA™ platform for neurology, oncology, & genetic diseases.
XCUR | NDAQ
Overview
Corporate Details
- ISIN(s):
- US30205M1018
- LEI:
- Country:
- United States of America
- Address:
- 2430 N. HALSTED ST., 60614 CHICAGO
- Website:
- https://www.exicuretx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Exicure, Inc. is an early-stage biotechnology company that has historically focused on developing nucleic acid therapies. The company's approach centered on its proprietary Spherical Nucleic Acid (SNA™) platform, designed to create therapeutics targeting ribonucleic acid (RNA). Its research and development efforts have targeted a range of indications, including neurological disorders, immuno-oncology, and genetic diseases. The SNA technology was developed to enhance the properties of nucleic acid-based treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all EXICURE, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EXICURE, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EXICURE, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
